Symbol
| NDRG1
| contributors: mct - updated : 31-01-2016
|
HGNC name
| N-myc downstream regulated 1
|
HGNC id
| 7679
|
corresponding disease(s)
|
CMT4D
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --low
|  
|
in colorectal neoplasmand in renal carcinoma | tumoral
|  
|  
| --over
|  
|
associated with angiogenesis and may be a poor prognostic indicator in women with cervical adenocarcinoma | tumoral
| fusion
|  
|  
|  
|
NDRG1-ERG fusion in prostate carcinoma is predicted to encode a chimeric protein | tumoral
|  
|  
| --low
|  
|
in glioma | constitutional
|  
|  
| --over
|  
|
led to decreased expression of the Wnt-responsive gene, CCND1 which drives cell cycle progression | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
| could be developed as a marker contributing to diagnosis and evaluating prognosis in gastric cancer | Therapy target
|
System | Type | Disorder | Pubmed |
cancer | digestive | stomach | |
potential therapeutic target of gastric cancer |
| | |
| being up-regulated in N-Myc knockout mouse embryos |